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Summary
Maternal smoking during pregnancy is associated with increased risk of childhood overweight
body mass index (BMI). Less is known about the association between prenatal secondhand
tobacco smoke (SHS) exposure and childhood BMI. We followed 292 mother-child dyads from
early pregnancy to 3 years of age. Prenatal tobacco smoke exposure during pregnancy was
quantified using self-report and serum cotinine biomarkers. We used linear mixed models to
estimate the association between tobacco smoke exposure and BMI at birth, 4 weeks, and 1, 2, and
3 years. During pregnancy, 15% of women reported SHS exposure and 12% reported active
smoking, but 51% of women had cotinine levels consistent with SHS exposure and 10% had
cotinine concentrations indicative of active smoking. After adjustment for confounders, children
born to active smokers had higher BMI at 2 and 3 years of age (self-report or serum cotinine),
compared to unexposed children. Children born to women with prenatal serum cotinine
concentrations indicative of SHS exposure had higher BMI at 2 (Mean Difference [MD]:0.3; 95%
confidence interval [CI]:−0.1, 0.7) and 3 (MD:0.4; [0, 0.8]) years compared to unexposed
children. Using self-reported prenatal exposure resulted in non-differential exposure
misclassification of SHS exposures that attenuated the association between SHS exposure and
BMI compared to serum cotinine concentrations. These findings suggest active and secondhand
prenatal tobacco smoke exposure may be related to an important public health problem in
childhood and later life. In addition, accurate quantification of prenatal secondhand tobacco smoke
exposures is essential to obtaining valid estimates.
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Between 15 and 20% of United States children have overweight body mass index (BMI) and
the proportion of children with overweight BMI is increasing in other countries.1, 2 Elevated
childhood BMI is associated with increased BMI and adiposity in adolescence and
adulthood.3, 4 Increased childhood BMI may also be a risk factor for metabolic disorders in
early adulthood and coronary heart disease in later adulthood.5, 6
Several studies have observed excess adiposity and increased risk of overweight or obese
BMI among children born to women who actively smoke during pregnancy compared to
children born to non-smokers.7–10 A recent meta-analysis of 14 studies indicates that
children born to active smokers have 1.5-times the risk of being overweight or obese as
children born to non-smokers.11 Increases in BMI and adiposity among children born to
active smokers may be due to decreased weight and length at birth, rapid weight gain after
birth, and decrements in height during childhood.10, 12–17
Less is known about the association between prenatal SHS exposure and childhood BMI.
We are aware of only two studies examining the association between prenatal secondhand
tobacco smoke (SHS) exposure and childhood BMI. Leary et al. reported elevated BMI,
total body fat, and truncal fat among 10-year old children whose mothers had a partner who
smoked during pregnancy.9 Oken et al. did not report any association between self-reported
prenatal SHS exposure and BMI at 3 years of age.8
Prior studies examining the association between prenatal active and SHS exposure and
childhood BMI have relied on self-reported exposures. Self-reported SHS exposures may
result in exposure misclassification that could bias the association between prenatal
exposure and childhood BMI.18–20 A prospectively collected, valid biomarker of exposure
might provide a more accurate estimate of the dose of tobacco smoke constituents received
by the mother and fetus.
Given widespread exposure to secondhand tobacco smoke,21 especially in newly
industrialized countries,22, 23 and the potential adverse health consequences of increased
childhood BMI, we investigated the association between prenatal tobacco smoke exposure
and early childhood BMI. In addition, we estimated and compared the associations between




We used data collected from mothers and their children participating in the Health
Outcomes and Measures of the Environment Study, an ongoing prospective birth cohort in
the Cincinnati metropolitan area designed to examine low-level environmental toxicant
exposure and the efficacy of injury and lead hazard controls in the home.24 Between March
of 2003 and January of 2006, women were identified from seven prenatal clinics associated
with three hospitals. We mailed letters to 5,512 women ≥ 18 years of age who were living in
a home built before 1978 to see if they were eligible and interested in participating in our
study. Additional eligibility criteria included: ≤ 19 weeks gestation upon enrollment; living
in Brown, Butler, Clermont, Hamilton, or Warren counties in Ohio; intention to continue
prenatal care and deliver at collaborating obstetric practices; HIV negative; and not
receiving seizure, thyroid, or chemotherapy/radiation medications. Of the 1,263 eligible
women, 468 enrolled in our study. The current analyses were further restricted to singleton
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children. We did not collect additional demographic information from women who refused
to participate.
Tobacco Smoke Measurements
Self-Reported Exposure—Women were interviewed twice about secondhand and active
tobacco smoke exposures for the periods between conception and 20 weeks (measured at 20
week home visit) and 20 weeks and birth (measured at 4 week postpartum visit) by trained
research staff. Trained interviewers asked the women the average number of cigarettes they
smoked per day (if any), the number of smokers living in the home, and the number of
cigarettes smoked per day in the home for each time period. Women were classified as
unexposed if they reported no exposure for all of pregnancy. Women with active exposure
during one or both periods were classified as active smokers. All others were classified as
having SHS exposure.
Serum and Meconium Biomarkers of Exposure—Women provided blood samples
around 16 weeks gestation, 26 weeks gestation, and within 24 hours of birth. All samples
were stored at −20° C until they were transported to the Centers for Disease Control and
Prevention (CDC) laboratory for analysis, where they were stored at or below −20° C.
Serum from each sample was analyzed for cotinine, a biomarker of nicotine exposure, using
high performance liquid chromatography-tandem mass spectroscopy (HPLC-MS/MS).25
The limit of detection (LOD) for this method was 0.015 ng/mL.
Prenatal serum cotinine concentrations were categorized as no exposure (<LOD), SHS
exposure (LOD to 3 ng/mL), and active exposure (>3 ng/mL). The threshold of 3 ng/mL for
active smoking was chosen based on results from the 1999–2004 National Health and
Nutrition Examination Survey using self-reported smoking status and serum cotinine levels
among a representative sample of the U.S. population.26 These results showed that using a
higher cutpoint of 15 ng/mL as the threshold for active smoking underestimates the
proportion of active smokers. Prenatal serum cotinine concentrations were also analyzed as a
continuous log10-transformed variable. In addition, we estimated the association between
continuous prenatal serum cotinine concentrations and BMI among women with no prenatal
active smoking (serum cotinine concentrations ≤3 ng/mL at each measurement).
Infant and Childhood Weight and Height Measurements—Birthweight and length
were abstracted from the child’s medical records. Subsequent weight and height
measurements were obtained by study staff in the child’s home or at our study clinic at 4
weeks and 1, 2, and 3 years of age. Each measurement was taken three times and the mean
was used in the analysis. Weight was measured at 4 weeks and 1 year with an infant scale
and at 2 and 3 years with a pediatric scale. Length at 4 weeks and 1 year was taken using a
length board. At 2 and 3 years, height was obtained using a stadiometer; however, if the
child was uncooperative at 2 years, we used a length board. We did not record whether
children’s length or height was measured at 2 years of age. BMI was calculated by dividing
weight in kilograms by height in meters squared. While BMI may not be an ideal measure of
excess adiposity before 2 years of age, the World Health Organization advocates using BMI
as a measure of adiposity in the first two years of life.27
BMI was modeled as a continuous and dichotomous outcome. BMI was dichotomized to
classify children as overweight at 2 or 3 years of age. We defined children as overweight if
they had age and sex specific BMI ≥ the 85th percentile at 2 or 3 years of age. 28
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We used directed acyclic graphs (DAGs) to examine the role of confounding by
sociodemographic, perinatal, and childhood nutrition factors in our exposure-outcome
relation.29 Sociodemographic covariates were collected at the baseline clinic visit and
included maternal age, race, education marital status, and household income. Perinatal
variables were maternal depression, maternal BMI at 16 weeks gestation, and parity.
Depression was measured at 20 weeks gestation with the Beck Depression Inventory (BDI-
II).30 Maternal BMI was modeled as a continuous variable from weight and height
measurements collected at the 16-week prenatal clinic visit. Parity was abstracted from
medical records. Breastfeeding was collected quarterly during telephone interviews and
included as a proxy of infant/childhood nutrition. We modeled breastfeeding as a time-
varying covariate coded as the length of time (in fractions of years) in which the child
received any breast milk since the last study visit. At birth, children were given a value of 0
years of breastfeeding.
The HOME Inventory, a semi-structured interview that assesses the quality of the caregiving
environment, was administered by trained interviewers during a home visit when the child
was 1 year old.31 The HOME score, as a continuous variable, was evaluated as an additional
proxy for socioeconomic status in a secondary analysis that examined the potential for
residual confounding after controlling for household income and maternal education. We did
not adjust for gestational age at birth since our DAG placed it on a causal pathway between
prenatal tobacco smoke exposure and childhood growth.
Statistical Analysis
We descriptively compared the demographic characteristics of mothers and their children
who had complete and missing covariate or exposure data. We also calculated the Pearson
correlation coefficients between log10-transformed prenatal serum cotinine concentrations at
each pair of time points.
We examined the shape of the relationship between log10-transformed prenatal serum
cotinine concentrations and children’s BMI at each measurement using Locally Weighted
Scatter Plot Smoothing (LOESS).32 We observed an approximately linear relationship
between log10-transformed prenatal serum cotinine concentration and BMI at each time.
Since our data involved repeated measurements on individuals, we used linear mixed models
to examine the association between prenatal tobacco smoke exposure and BMI over the first
3 years of life.33 Models were fit with time since birth (i.e., age in years), time-squared, and
time-cubed terms. We allowed the association between prenatal tobacco smoke exposure
and childhood size to vary over time by including interaction terms between tobacco smoke
exposure and time variables. Tobacco smoke parameter estimates from our categorical
models represent the mean change in BMI from the reference category, while estimates from
models using continuous cotinine concentrations represent the mean change for each unit
increase in log10-transformed (i.e., 10-fold increase) serum cotinine concentrations.
We used logistic regression with generalized estimating equations to estimate the association
between secondhand and active prenatal tobacco smoke exposure and being overweight
(BMI ≥ 85th percentile) at 2 or 3 years of age.34 We generated odds ratios (OR) for being
overweight given prenatal exposure to secondhand or active tobacco smoke compared to no
exposure. We assessed the precision of our difference and ratio estimates using the
confidence limit difference (CLD) and confidence limit ratio (CLR), respectively.35
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We examined which component of BMI was responsible for associations between prenatal
tobacco smoke exposure and BMI by constructing linear mixed models using categorical
prenatal serum cotinine concentrations as the predictor variable and continuous weight or
height z-scores at birth, 4 weeks, and 1, 2, and 3 years as the outcome. We calculated weight
and height z-scores using publicly available software from the National Center for Health
Statistics.36 We repeated our analyses using data from participants who had BMI
measurements from all four follow-up visits to determine if children with incomplete data
had excessive influence on our results. Finally, we constructed linear mixed models to
analyze the association between individual serum cotinine concentrations (16 week, 26
week, and birth) and BMI over the first 3 years of life.
Ethical Considerations
The Institutional Review Boards (IRB) of the University of North Carolina-Chapel Hill and
Cincinnati Children’s Hospital Medical Center approved this study. The Cincinnati
Children’s Hospital Medical Center IRB was involved in the oversight of this study. All
mothers provided written informed consent for themselves and their children prior to
enrollment in the study.
Results
Of the 468 women who initially enrolled in our study, 67 dropped out before delivery. We
excluded 9 non-singleton and 3 still-born children. Of the remaining 389 women and infants,
at least two prenatal serum cotinine samples were collected and assayed from 384 (99%)
women and self-reported prenatal tobacco smoke exposure was collected from 356 (92%)
women. A higher proportion of women with complete self-report, serum cotinine, and
covariate data at birth (N=292, 75%) were non-Hispanic white, better educated, wealthier,
married, multiparous, and 25–34 years of age than women with missing data (Table 1). Of
these women and infants, 202 (52%) had complete covariate and follow up data at 3 years of
age.
Nearly half of women (48%) with no self-report of prenatal tobacco smoke exposure had
serum cotinine concentrations indicative of secondhand exposure (Table 2). Almost 84% of
women who self-reported active smoking had corresponding serum cotinine concentrations.
Among women with prenatal serum cotinine concentrations indicative of SHS exposure,
geometric mean (GM) serum cotinine concentrations were higher among women with self-
reported prenatal SHS exposure (GM: 0.19) compared to women without self-reported
prenatal SHS exposure (GM: 0.06). Pairs of prenatal serum cotinine concentrations taken at
different times during pregnancy were highly correlated (Pearson R=0.7–0.8).
After adjustment for confounders, the point estimates of the mean BMI difference between
actively exposed and unexposed children rose as children grew older (Table 3). The
estimates were imprecise and became even more so over time with participant attrition. For
self-reported active exposure, the 95% CI was wider at 3 years of age (CLD: 1.3 BMI units)
than it was at birth (CLD: 1.0 BMI units). The point estimates and pattern of estimates over
time was similar using self-report or serum cotinine concentrations to classify prenatal
active tobacco smoke exposure. The HOME inventory score did not improve adjustment for
socioeconomic confounding over maternal education and household income and was not
retained in our models.
The associations between self-reported prenatal SHS exposure and BMI were very close to
the null value at every time point (Table 3). However, point estimates between serum
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cotinine concentrations indicative of SHS exposure and BMI rose as children grew older.
Again, these estimates became less precise because of participant attrition over time.
Odds of overweight BMI among children born to smokers were similar when exposure was
classified with self-report or serum cotinine concentrations (Table 4). Estimates using self-
report were more precise than estimates using serum cotinine concentrations (CLR: 16 vs.
10). The magnitude of association between SHS exposure and overweight BMI was greater
and more precise when exposure was quantified using prenatal serum cotinine
concentrations (OR: 1.9; [0.8, 4.4], CLR: 5.5) compared to self-report (OR: 1.0; [0.3, 3.0],
CLR: 10).
Secondary Analyses
Associations between prenatal secondhand and active tobacco smoke exposure and birth
weight were below the null and imprecise (Mean Difference [MD] SHS vs. unexposed:
−112, [−268, 33], CLD: 302; MD active vs. unexposed: −136; [−405, 132], CLD: 537).
Children born to exposed women were shorter in length than unexposed children (MD SHS
vs. unexposed: −0.8, [−1.5, −0.1]; MD active vs. unexposed: −1.2; [−2.4, 0]). Increased BMI
at 2 and 3 years of age was the result of increased weight among prenatally exposed children
at 2 and 3 years of age compared to unexposed children (Figure 1). In contrast, height at 1,
2, or 3 years of age was similar across categories of prenatal tobacco smoke exposure using
self-report or serum cotinine concentrations (results for serum cotinine shown in Figure 1).
Our associations between prenatal serum cotinine concentrations and early childhood BMI
were strengthened and less precise when we restricted analyses to the 194 children who
completed all 4 follow-up visits. For example, at 3 years of age children with prenatal
secondhand (MD: 0.5; [0.1, 1.0]; CLD: 0.9) and active (MD: 1.4; [0.5, 2.3], CLD: 1.8)
serum cotinine concentrations had higher BMI at 3 years compared to unexposed children.
Results from models separately examining 16 week, 26 week, and birth serum cotinine
concentrations in relation to BMI were relatively similar to results using mean prenatal
serum cotinine concentrations. Point estimates using individual or mean serum cotinine were
similar in magnitude and precision for prenatal active tobacco smoke exposure. The point
estimates for SHS were somewhat higher from serum cotinine concentrations taken at 26
weeks and birth compared to 16 week serum concentration estimates, but similar to mean
prenatal serum cotinine concentration estimates.
Discussion
Active prenatal tobacco smoke exposure, classified using self-report or serum cotinine
concentrations, was imprecisely associated with higher BMI and odds of overweight BMI at
2 or 3 years of age compared to unexposed children. Our results using serum cotinine
concentrations were more suggestive of increased BMI among children with prenatal SHS
exposure than the results using self-reported exposures. Self-reported secondhand tobacco
smoke exposures were misclassified to a greater extent than self-reported active smoking,
and accordingly, the point estimates were attenuated when compared to estimates based on
serum cotinine concentrations.
Prior studies of prenatal tobacco smoke exposure and BMI have relied on self-reported
tobacco smoke exposures and many studies have compared actively smoking women to non-
smokers, without considering the impact SHS exposure. This misclassification may have
contributed to an underestimate of the impact of active prenatal tobacco smoke exposure on
childhood BMI. Our results show that self-reported tobacco smoke measures fail to
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accurately quantify secondhand tobacco smoke exposures and may result in biased estimates
of association.
Several investigators have reported increased BMI and risk of overweight BMI among 2–4
year old children born to active smokers.7, 8, 10, 11, 37 ORs between prenatal active smoking
and overweight BMI in prior studies range from 1.2 to 2.2.7, 8, 10, 37 Our estimated
association between active smoking and BMI were less precise than prior estimates, similar
to Oken et al. and Adams et al. (OR: 2.2),7, 8 and larger than Chen et al. and Whitaker et al.
(OR: 1.2–1.5).10, 37
Consistent with our findings, Oken and colleagues did not report increased BMI among 3
year old children born to women with self-reported prenatal secondhand tobacco smoke
exposure.8 However, Leary et al. reported that 10 year old children born to women whose
partners smoked regularly during pregnancy had BMI 0.1 standard deviations higher than
unexposed children.9 The discrepancy in results could be due to differences in the tobacco
smoke exposure questionnaire, temporal or geographic variations in secondhand exposure,
or the age of follow-up.
Increased weight at 2 or 3 years of age was responsible for increases in BMI among children
born to women with serum cotinine concentrations consistent with secondhand and active
tobacco smoke exposures. Children with prenatal tobacco smoke exposures were born
lighter and shorter and grew heavier over the first 3 years of life compared to unexposed
children. Attained height at 1, 2, or 3 years of age was similar between categories of prenatal
tobacco smoke exposure.
Prenatal tobacco smoke exposure may influence childhood BMI by restricting fetal growth
as a result of vascocontriction and hypoxemia.14–16, 38 Restricted fetal growth may lead to
rapid weight gain, resulting in increased BMI and adiposity during early childhood.16, 39 In
addition, tobacco smoke constituents may act on various hormonal systems that change
metabolic programming.40, 41 There has also been some suggestion that prenatal tobacco
smoke exposure may alter infant appetite and leptin concentrations.42–44
The results of this study should be considered in light of several limitations. Confounding
due to dietary, lifestyle, or socioeconomic factors may eliminate the observed elevation in
BMI among children born to women with serum cotinine concentrations indicative of SHS
exposure. Women who smoke or are exposed to higher levels of SHS during pregnancy are
less likely to provide optimal diets and exercise for their children.45, 46 Residual
confounding may eliminate the positive association between prenatal secondhand tobacco
smoke exposure and BMI at 2 and 3 years of age. We attempted to indirectly control for
confounding due to dietary or lifestyle factors by including breast feeding duration and
maternal BMI in our models. In addition, we controlled for other markers of socioeconomic
status, including household income and maternal education which are associated with diet
and exercise.47, 48 We also used HOME Inventory scores as a proxy for socioeconomic,
dietary, and exercise factors not captured by other variables. Our results were not
substantially different when we included HOME Inventory scores in our models.
While serum cotinine is considered an ideal biomarker for tobacco smoke exposure, it only
reflects exposure over the last 2 to 3 days, which introduces the potential for exposure
misclassification.49, 50 Women could have been exposed intermittently (e.g., only on
weekends). However, we do not believe this is a substantial source of bias since maternal
serial serum cotinine concentrations were highly correlated and we used 2 or more prenatal
serum samples from each woman to quantify prenatal exposure.
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Increased BMI can result from increases in fat mass or fat-free mass. Other measures of
body composition, including densitometry, bioelectric impedance, dual energy x-ray
absorptiometry (DXA), and isotope dilution can derive these separate components of body
composition and provide more accurate quantification of excess adiposity.51 In addition,
BMI is differentially correlated with direct measures of adiposity, with higher correlation
among children ≥ 85th BMI percentile.52 While there are limitations to using BMI as a
marker of early childhood adiposity, BMI is endorsed by the World Health Organization to
measure and track body composition across the life-course.27 In addition, prior studies
report that BMI measurements before 2 years of age are correlated with other direct
measures of adiposity.53 Future research should examine the association between prenatal
tobacco smoke exposures using direct measures of fat and fat-free mass and study children
in later childhood when BMI measurements become more reflective of adult adiposity.4
A substantial proportion of women and their children dropped out of the study by 3 years of
age. Attrition in our study was associated with socioeconomic factors, which are related to
health and caregiving behaviors that influence childhood adiposity and tobacco smoke
exposures. The association between prenatal serum cotinine concentrations and BMI was
slightly strengthened when we restricted to children who completed all four follow-up visits.
Women in this study were required to be living in housing built before 1978. We do not
believe this limits the generalizability of our study, since almost 70% of US housing units
were built prior to 1978.54 However, we analyzed a relatively homogenous sample of
mothers who come from higher socioeconomic backgrounds which may reduce the
generalizability of these results to samples drawn from populations with lower SES.
These results suggest that prenatal serum cotinine concentrations may be associated with
increased BMI and odds of overweight BMI at 2 and 3 years of age. Given the high
prevalence of tobacco smoke exposure and detrimental health consequences of increased
BMI, additional research should be conducted examining the relationship between prenatal
SHS exposures and childhood BMI and adiposity. Specifically, future studies should use
validated biomarkers of tobacco smoke exposure to reduce misclassification of SHS
exposure and examine this association at later ages. The presented findings add to a growing
body of literature suggesting that prenatal environmental insults, including secondhand
tobacco smoke exposure, may impact the public’s health by influencing the risk of later life
health outcomes through excess childhood BMI.55, 56
Acknowledgments
Funding: This study was supported by the NICHD Reproductive, Perinatal, and Pediatric Epidemiology Training
Grant (T32-HD052468-01), a grant from the National Institute of Environmental Health Sciences (P30ES10126),
and from a Children’s Environmental Health Center Grant from the National Institute of Environmental Health
Sciences and the US Environmental Protection Agency (PO1 ES11261).
We would like to acknowledge the mothers, children, and study staff that made the HOME study possible. We are
grateful for Dr. Amy Kalkbrenner’s feedback on this manuscript.
References
1. De Onis M, Blossner M. Prevalence and trends of overweight among preschool chidlren in
developing countries. Am J Clin Nutr. 2000; 72:1032–1039. [PubMed: 11010948]
2. Prevalence of overweight among chidlren and adolescents: United States, 2003–2004. National
Center for Health Statistics; 2009. [updated 2009; cited 2010 Jan 5]; Available from: http://
www.cdc.gov/nchs/data/hestat/overweight/overwght_child_03.htm
3. Sachdev HS, Fall CH, Osmond C, Lakshmy R, Dey Biswas SK, Leary SD, et al. Anthropometric
indicators of body composition in young adults: relation to size at birth and serial measurements of
Braun et al. Page 8










body mass index in childhood in the New Delhi birth cohort. Am J Clin Nutr. 2005; 82:456–466.
[PubMed: 16087993]
4. Yliharsila H, Kajantie E, Osmond C, Forsen T, Barker DJ, Eriksson JG. Body mass index during
childhood and adult body composition in men and women aged 56–70 y. Am J Clin Nutr. 2008;
87:1769–1775. [PubMed: 18541567]
5. Reilly JJ, Methven E, McDowell ZC, Hacking B, Alexander D, Stewart L, et al. Health
consequences of obesity. Arch Dis Child. 2003; 88:748–752. [PubMed: 12937090]
6. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart
disease in adulthood. N Engl J Med. 2007; 357:2329–2337. [PubMed: 18057335]
7. Adams AK, Harvey HE, Prince RJ. Association of maternal smoking with overweight at age 3 y in
American Indian children. Am J Clin Nutr. 2005; 82:393–398. [PubMed: 16087984]
8. Oken E, Huh SY, Taveras EM, Rich-Edwards JW, Gillman MW. Associations of maternal prenatal
smoking with child adiposity and blood pressure. Obes Res. 2005; 13:2021–2028. [PubMed:
16339135]
9. Leary SD, Smith GD, Rogers IS, Reilly JJ, Wells JC, Ness AR. Smoking during pregnancy and
offspring fat and lean mass in childhood. Obesity (Silver Spring). 2006; 14:2284–2293. [PubMed:
17189557]
10. Chen A, Pennell ML, Klebanoff MA, Rogan WJ, Longnecker MP. Maternal smoking during
pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol. 2006;
35:121–130. [PubMed: 16260450]
11. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight:
systematic review and meta-analysis. Int J Obes (Lond). 2008; 32:201–210. [PubMed: 18278059]
12. The health consequences of smoking: A report of the Surgeon General. Washington, D.C: Dept. of
Health and Human Services, Centers for Disease Control and Prevention, National Center for
Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 2004. Contract
No.: Document Number|
13. Hamilton BH. Estimating treatment effects in randomized clinical trials with non-compliance: the
impact of maternal smoking on birthweight. Health Econ. 2001; 10:399–410. [PubMed:
11466802]
14. Williams SM. Weight and height growth rate and the timing of adiposity rebound. Obes Res. 2005;
13:1123–1130. [PubMed: 15976156]
15. Williams SM, Goulding A. Early adiposity rebound is an important predictor of later obesity.
Obesity (Silver Spring). 2009; 17:1310. [PubMed: 19553922]
16. Hui LL, Schooling CM, Leung SS, Mak KH, Ho LM, Lam TH, et al. Birth weight, infant growth,
and childhood body mass index: Hong Kong’s children of 1997 birth cohort. Arch Pediatr Adolesc
Med. 2008; 162:212–218. [PubMed: 18316657]
17. Williams SM, Goulding A. Patterns of growth associated with the timing of adiposity rebound.
Obesity (Silver Spring). 2009; 17:335–341. [PubMed: 19057527]
18. DeLorenze GN, Kharrazi M, Kaufman FL, Eskenazi B, Bernert JT. Exposure to environmental
tobacco smoke in pregnant women: the association between self-report and serum cotinine.
Environ Res. 2002; 90:21–32. [PubMed: 12359187]
19. Kaufman FL, Kharrazi M, Delorenze GN, Eskenazi B, Bernert JT. Estimation of environmental
tobacco smoke exposure during pregnancy using a single question on household smokers versus
serum cotinine. J Expo Anal Environ Epidemiol. 2002; 12:286–295. [PubMed: 12087435]
20. George L, Granath F, Johansson AL, Cnattingius S. Self-reported nicotine exposure and plasma
levels of cotinine in early and late pregnancy. Acta Obstet Gynecol Scand. 2006; 85:1331–1337.
[PubMed: 17091413]
21. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers
in the U.S. population to secondhand smoke: 1988–2002. Environ Health Perspect. 2006;
114:853–858. [PubMed: 16759984]
22. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, et al. Smoking in China: findings of the 1996
National Prevalence Survey. Jama. 1999; 282:1247–1253. [PubMed: 10517427]
23. Gupta D, Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Jindal SK, et al. Household
environmental tobacco smoke exposure, respiratory symptoms and asthma in non-smoker adults: a
Braun et al. Page 9










multicentric population study from India. Indian J Chest Dis Allied Sci. 2006; 48:31–36.
[PubMed: 16482949]
24. Dietrich KN, Eskenazi B, Schantz S, Yolton K, Rauh VA, Johnson CB, et al. Principles and
practices of neurodevelopmental assessment in children: lessons learned from the Centers for
Children’s Environmental Health and Disease Prevention Research. Environ Health Perspect.
2005; 113:1437–1446. [PubMed: 16203260]
25. Bernert JT Jr, McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine
measurements by a sensitive high-performance liquid chromatography-tandem mass spectrometry
method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal
Toxicol. 2000; 24:333–339. [PubMed: 10926356]
26. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for
distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the
United States between 1999 and 2004. Am J Epidemiol. 2009; 169:236–248. [PubMed: 19019851]
27. WHO. WHO Child Growth Standards: Methods and development: Length/height-for-age, weight-
for-age, weight-for-length, weight-for-height and body mass index-forage. Geneva: World Health
Organization; 2006. Contract No.: Document Number|
28. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, et al. CDC growth
charts: United States. Adv Data. 2000:1–27. [PubMed: 11183293]
29. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology.
1999; 10:37–48. [PubMed: 9888278]
30. Beck, AT.; Steer, RA.; Brown, GK. Beck Depression Inventory. 2. San Antonio: The
Psychological Corporation; 1996. (BDI-II)
31. Caldwell, B.; Bradley, R. HOME Inventory Administration Manual. Little Rock, AK: University
of Arkansas at Little Rock; 2003.
32. Cleveland WS. Robust Locally Weighted Regression and Smoothing Scatterplots. Journal of the
American Statistical Association. 1979; 74:829–836.
33. Fitzmaurice, GM.; Laird, NM.; Ware, JH. Applied Longitudinal Data Analysis. 2. Hoboken:
Wiley; 2004.
34. CDC. 2000 CDC Growth Charts: United States. Hyattsville, MD: 2009. [updated 2009; cited 2009
July 1]; Available from: http://www.cdc.gov/GrowthCharts/
35. Poole C. Low P-values or narrow confidence intervals: which are more durable? Epidemiology.
2001; 12:291–294. [PubMed: 11337599]
36. A SAS Program for the CDC Growth Charts. Centers for Disease Control and Prevention: National
Center for Health Statistics; 2009. [updated 2009; cited 2009 November 1]; Available from: http://
www.cdc.gov/nccdphp/dnpao/growthcharts/resources/sas.htm
37. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early
pregnancy. Pediatrics. 2004; 114:e29–e36. [PubMed: 15231970]
38. Lambers DS, Clark KE. The maternal and fetal physiologic effects of nicotine. Semin Perinatol.
1996; 20:115–126. [PubMed: 8857697]
39. Ong KK, Preece MA, Emmett PM, Ahmed ML, Dunger DB. Size at birth and early childhood
growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort
study and analysis. Pediatr Res. 2002; 52:863–867. [PubMed: 12438662]
40. Levin ED. Fetal nicotine overload, blunted sympathetic responsivity, and obesity. Birth Defects
Res A Clin Mol Teratol. 2005
41. Oncken CA, Henry KM, Campbell WA, Kuhn CM, Slotkin TA, Kranzler HR. Effect of maternal
smoking on fetal catecholamine concentrations at birth. Pediatr Res. 2003; 53:119–124. [PubMed:
12508090]
42. Helland IB, Reseland JE, Saugstad OD, Drevon CA. Smoking related to plasma leptin
concentration in pregnant women and their newborn infants. Acta Paediatr. 2001; 90:282–287.
[PubMed: 11332168]
43. Pardo IM, Geloneze B, Tambascia MA, Barros-Filho AA. Does maternal smoking influence leptin
levels in term, appropriate-for-gestational-age newborns? J Matern Fetal Neonatal Med. 2004;
15:408–410. [PubMed: 15280113]
Braun et al. Page 10










44. Toschke AM, Ehlin AG, von Kries R, Ekbom A, Montgomery SM. Maternal smoking during
pregnancy and appetite control in offspring. J Perinat Med. 2003; 31:251–256. [PubMed:
12825482]
45. Burke V, Gracey MP, Milligan RA, Thompson C, Taggart AC, Beilin LJ. Parental smoking and
risk factors for cardiovascular disease in 10- to 12-year-old children. J Pediatr. 1998; 133:206–
213. [PubMed: 9709707]
46. Rogers I, Emmett P. The effect of maternal smoking status, educational level and age on food and
nutrient intakes in preschool children: results from the Avon Longitudinal Study of Parents and
Children. Eur J Clin Nutr. 2003; 57:854–864. [PubMed: 12821885]
47. Parsons TJ, Power C, Logan S, Summerbell CD. Childhood predictors of adult obesity: a
systematic review. Int J Obes Relat Metab Disord. 1999; 23 (Suppl 8):S1–107. [PubMed:
10641588]
48. Power C, Parsons T. Nutritional and other influences in childhood as predictors of adult obesity.
Proc Nutr Soc. 2000; 59:267–272. [PubMed: 10946795]
49. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev.
1996; 18:188–204. [PubMed: 9021312]
50. Benowitz NL. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect.
1999; 107 (Suppl 2):349–355. [PubMed: 10350520]
51. Wells JC. A critique of the expression of paediatric body composition data. Arch Dis Child. 2001;
85:67–72. [PubMed: 11420208]
52. Freedman DS, Wang J, Maynard LM, Thornton JC, Mei Z, Pierson RN, et al. Relation of BMI to
fat and fat-free mass among children and adolescents. Int J Obes (Lond). 2005; 29:1–8. [PubMed:
15278104]
53. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad
V. Adiposity indices in children. Am J Clin Nutr. 1982; 36:178–184. [PubMed: 7091028]
54. Jacobs DE, Clickner RP, Zhou JY, Viet SM, Marker DA, Rogers JW, et al. The prevalence of lead-
based paint hazards in U.S. housing. Environ Health Perspect. 2002; 110:A599–606. [PubMed:
12361941]
55. Gillman MW. Developmental origins of health and disease. N Engl J Med. 2005; 353:1848–1850.
[PubMed: 16251542]
56. Gillman MW, Rifas-Shiman SL, Kleinman K, Oken E, Rich-Edwards JW, Taveras EM.
Developmental origins of childhood overweight: potential public health impact. Obesity (Silver
Spring). 2008; 16:1651–1656. [PubMed: 18451768]
Braun et al. Page 11











Mean weight and height z-score from birth to 3 years of age by prenatal serum cotinine
category.* †
*-Adjusted for child age (in years), child age squared, child age cubed, maternal age (<25,
25–34, and >34 years), education (<12, 12, and >12 years), race (non-Hispanic white, non-
Hispanic black, and other), marital status (married and non-married), depression at baseline
home visit (moderately or severely depressed and mildly or minimally depressed), breast
feeding duration since last visit (years), parity (0, 1, and >1), income ($10,000 increments),
and maternal BMI at 16 weeks gestation.
†-Bars represent 95% confidence intervals
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Table 1
Distribution of demographic, perinatal, anthropometric, and tobacco smoke exposure variables among mothers
in Health Outcomes and Measures of the Environment study
Variable All Mothers and Infants
N =389 (%)
Mothers and Infants with
Complete Data
N=292 (%)




 Non-Hispanic White 237 (62) 191 (65) 46 (50)
 Non-Hispanic Black 121 (31) 84 (29) 37 (40)
 Other 26 (7) 17 (6) 9 (10)
 Missing 5 0 5
Maternal Education (years)
 <12 41 (11) 27 (9) 14 (15)
 12 54 (14) 36 (12) 18 (20)
 >12 289 (75) 229 (78) 60 (65)
 Missing 5 0 5
Marital Status
 Married 249 (65) 197 (67) 52 (57)
 Single 135 (35) 95 (33) 40 (43)
 Missing 5 0 5
Maternal Age Category (years)
 <25 96 (25) 60 (20) 35 (37)
 25–34 231 (59) 181 (62) 50 (52)
 35+ 62 (16) 51 (18) 11 (11)
 Missing 0 0 0
BDI at 20 Weeks
 Minimal Depression (0–13) 291 (78) 232 (79) 59 (71)
 Mild Depression (14–19) 54 (14) 35 (12) 19 (23)
 Moderate or Severe Depression (20–28) 30 (8) 25 (9) 5 (6)
 Missing 14 0 14
Parity
 0 171 (44) 122 (42) 49 (52)
 1 124 (32) 91 (31) 33 (35)
 >1 92 (24) 79 (27) 13 (14)
 Missing 2 0 2
Prenatal Serum Cotinine Category
 <LOD 140 (37) 114 (39) 26 (28)
 LOD to 3 ng/mL 199 (52) 147 (50) 52 (57)
 >3 ng/mL 45 (12) 31 (11) 14 (15)
 Missing 5 0 5
Mean Maternal Weight at Baseline (SD) 70 (61, 84) 70 (61, 82) 72 (60, 87)
 Missing 5 0 5
Mean Maternal Height at Baseline (SD) 165 (160, 169) 165 (160, 169) 165 (160, 170)
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Variable All Mothers and Infants
N =389 (%)
Mothers and Infants with
Complete Data
N=292 (%)
Mothers and Infants with
Missing Data
N=97 (%)
 Missing 20 0 20
Mean BMI at Baseline (SD) 26 (23, 30) 26 (23, 30) 27 (23, 31)
 Missing 26 0 26
Median Income in Thousands of Dollars (IQR) 55 (25, 85) 55 (25, 85) 35 (15, 75)
 Missing 13 0 13
Median Total Weeks of Breast Feeding (IQR) 14 (1, 40) 15 (2, 41) 9 (1, 32)
 Missing 58 0 58
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Table 2








Unexposed (<LOD) 108 (50) 5 (12) 1 (3)
SHS Exposure (LOD – 3ng/mL) 103 (48) 35 (83) 9 (25)
Active Exposure (> 3ng/mL) 3 (1) 2 (5) 26 (72)
Median Serum Cotinine
Concentration (Min, Max)
0.015 (<LOD, 14.9) 0.134 (<LOD, 3.92) 35.3 (<LOD, 355.5)
*
-Limited to women with complete covariate data.
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Table 4
Unadjusted and adjusted association between categorical prenatal tobacco smoke exposure and overweight
BMI at 2 or 3 years of age*
Total >85th Cases (%) >85th Unadjusted OR [95% CI] >85th Adjusted OR [95% CI]
Self-Reported Prenatal Tobacco Smoke Category
 Unexposed 307 43 (14) Reference Reference
 SHS 56 9 (16) 1.2 [0.5, 3.1] 1.0 [0.3, 3.0]
 Active 48 14 (29) 2.5 [1.0, 6.1] 1.9 [0.6, 6.1]
Categorical Prenatal Serum Cotinine Concentrations
 Unexposed (<0.015 ng/mL) 176 18 (10) Reference Reference
 SHS (0.015–3 ng/mL) 209 40 (19) 2.1 [1.0, 4.5] 1.9 [0.8, 4.4]
 Active (>3 ng/mL) 40 10 (25) 3.3 [1.1, 10.0] 2.4 [0.6, 9.7]
*
-Adjusted for maternal age (<25, 25–34, and >34 years), education (<12, 12, and >12 years), race (non-Hispanic white, non-Hispanic black, and
other), marital status (married and non-married), depression at baseline home visit (moderately or severely depressed and mildly or minimally
depressed), breast feeding duration (years), parity (0, 1, and >1), income ($10,000 increments), and maternal BMI (kg/m2) at 16 weeks gestation.
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